Research

Read the Research

Filter
All
WNT5A-ATF3-FOSB: Can This New Pathway Regrow Hair?
01
11 September 2026
WNT5A-ATF3-FOSB: Can This New Pathway Regrow Hair?
A single-cell RNA sequencing study published in the past month has identified a new signalling pathway that appears to be switched off in balding hair follic...
Read article
ABS-201 for Hair Loss: Can Blocking Prolactin Regrow Hair?
02
01 September 2026
ABS-201 for Hair Loss: Can Blocking Prolactin Regrow Hair?
Most hair loss drugs in development still work somewhere along the androgen pathway, the same territory finasteride and dutasteride occupy. ABS-201, develope...
Read article
Topical Cetirizine for Hair Loss: Can an Antihistamine Regrow Hair?
03
30 August 2026
Topical Cetirizine for Hair Loss: Can an Antihistamine Regrow Hair?
Cetirizine is a second-generation antihistamine, sold over the counter for hay fever and hives. It has no obvious connection to hair. The rationale for using...
Read article
Tretinoin for Hair Loss: Does It Work Without Minoxidil?
04
28 August 2026
Tretinoin for Hair Loss: Does It Work Without Minoxidil?
Tretinoin comes up constantly in hair loss discussions, almost always attached to minoxidil. The standard claim is that tretinoin helps minoxidil work better...
Read article
KX-826 vs Breezula: Which Topical Antiandrogen Is Actually Ahead?
05
25 August 2026
KX-826 vs Breezula: Which Topical Antiandrogen Is Actually Ahead?
Two companies, on two continents, are racing to bring a topical androgen receptor antagonist to market for pattern hair loss: Cosmo Pharmaceuticals with clas...
Read article
KX-826 vs RU58841: One Has Clinical Trials. The Other Doesn't
06
25 August 2026
KX-826 vs RU58841: One Has Clinical Trials. The Other Doesn't
KX-826, also known as pyrilutamide, is a topical androgen receptor antagonist developed by Kintor Pharmaceutical, a publicly listed Chinese biotech. It's the...
Read article
KX-826 (Pyrilutamide) From Phase 1 to Phase 3: What We Know Now
07
25 August 2026
KX-826 (Pyrilutamide) From Phase 1 to Phase 3: What We Know Now
KX-826, also known as pyrilutamide, is a topical androgen receptor antagonist developed by Kintor Pharmaceutical (HKEX: 9939), a publicly listed biotech base...
Read article
RU58841 Reaches the Bloodstream: Here's Why It's a Problem
08
23 August 2026
RU58841 Reaches the Bloodstream: Here's Why It's a Problem
RU58841 is a topical androgen receptor antagonist, an unapproved compound sold through research-chemical suppliers and used off-label by parts of the hair lo...
Read article
VDPHL01 vs Oral Minoxidil: Even Worse Fluid Retention?
09
21 August 2026
VDPHL01 vs Oral Minoxidil: Even Worse Fluid Retention?
Search around for VDPHL01 and you'll find fluid retention mentioned constantly, usually as a reason people avoid oral minoxidil altogether, and usually impli...
Read article
VDPHL01 for Hair Loss: What the New Oral Minoxidil Does Differently
10
15 August 2026
VDPHL01 for Hair Loss: What the New Oral Minoxidil Does Differently
Our earlier article on oral minoxidil covered the current shift toward oral prescribing, and made a point of noting that the tablets being prescribed are imm...
Read article